{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:36:54Z","timestamp":1768282614888,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.mmcr.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T07:01:22Z","timestamp":1457420482000},"page":"36-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Isavuconazole as salvage therapy for mucormycosis"],"prefix":"10.1016","volume":"11","author":[{"given":"Bianca","family":"Graves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Orla","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Coutsouvelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Gooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Ananda-Rajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Supp. 1","key":"10.1016\/j.mmcr.2016.03.002_bib1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mmcr.2016.03.002_bib2","unstructured":"A. Skiada, F. Lanternier, A.H. Groll, L. Pagano, S. Zimmerli, R. Herbrecht, O. Lortholary, G.I. Petrikkos, Diagnosis and treatment of mucormycosis in patients with haematological malignancies: guidelines from the 3rd European Conference on Infections in Leukaemia (ECIL 3), Haeamtologica 98 (4) (2013), pp. 492\u2013504."},{"key":"10.1016\/j.mmcr.2016.03.002_bib3","unstructured":"Astellas: FDA Advisory Committee Briefing Document: Isavuconium \u2013 Invasive Aspergillosis and Invasive Mucormycosis. \u3008www.fda.gov\/downloads\u3009"},{"key":"10.1016\/j.mmcr.2016.03.002_bib4","doi-asserted-by":"crossref","unstructured":"F.M. Marty, J.R. Perfect, O.A. Cornely, et al., An open-label Phase 3 study of isavuconazole (VITAL): focus on mucormycosis. Presented at: ID week ASM. PA, USA 8\u201312 October 2014 (Abstract no. 824)","DOI":"10.1093\/ofid\/ofu052.532"},{"issue":"5","key":"10.1016\/j.mmcr.2016.03.002_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/fmb.15.34","article-title":"Isavuconazole: a new extended spectrum triazole for invasive mould infections","volume":"10","author":"Ananda-Rajah","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.mmcr.2016.03.002_bib6","first-page":"503","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"47","author":"Roden","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.mmcr.2016.03.002_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with haematological malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"Supp. 1","key":"10.1016\/j.mmcr.2016.03.002_bib8","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mmcr.2016.03.002_bib9","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1469-0691.2009.02985.x","article-title":"Current experience in treating invasive zygomycosis with posaconazole","volume":"15","author":"Cornley","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.mmcr.2016.03.002_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/AAC.01325-10","article-title":"Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy","volume":"55","author":"Shields","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mmcr.2016.03.002_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s15010-013-0552-6","article-title":"Successful isavuconazole salvage therapy in a patient with invasive mucormycosis","volume":"42","author":"Ervens","year":"2014","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.mmcr.2016.03.002_bib12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/JCM.03176-13","article-title":"Isavuconazole treatment of a patient with disseminated mucormycosis","volume":"52","author":"Peixoto","year":"2014","journal-title":"J. Clin. Microbiol."}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753916300082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753916300082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T09:26:34Z","timestamp":1567675594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753916300082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":12,"alternative-id":["S2211753916300082"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2016.03.002","relation":{},"ISSN":["2211-7539"],"issn-type":[{"value":"2211-7539","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isavuconazole as salvage therapy for mucormycosis","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.","name":"copyright","label":"Copyright"}]}}